Connect with us

Cannabis Living

Jamaicas Cannabis based treatment for acute myeloid leukaemia

Share

Cancer

Jamaicas Cannabis based treatment for acute myeloid leukaemia

By

CL Editor

Published on 9th November 2017

Share

Comment

A Jamaican scientist has seen his cannabis-derived anti-cancer drug receive FDA approval.

Dr Lowe, who founded Medicanja Ltd — described as “Jamaica’s first medical cannabis company” — in 2013, has developed Chrysoeriol, a cannabis-based drug used to treat acute myeloid leukaemia.

He is hoping to raise $3.5 million to continue his research and ready the drug for the retail market in about two to three years’ time.

More in Cancer

Cancer

Hold the bucket! CBD exerts an anti nausea and vomiting effect.

By CL Editor8th February 2018

Cannabinoids exert an anti-emetic effect. Pre-clinical research shows CBD could be an effective treatment for chemotherapy...
Cancer

Medical cannabis studies in London

By CL Editor16th November 2017

It’s an exciting time for medical cannabis across the world, and despite the UK governments reluctance...
Cancer

Talking terpenes

By CL Editor8th November 2017

Introducing Myrcene. With thoughts turning to terpenes to enhance cannabis’s potential we wanted to look at...
Cancer

Bad science of a good plant

By CL Editor31st October 2017

This undervalued plant needs much greater investment internationally to enable it to fulfil its vast potential....
Cancer

Cancerous tumour shrinks using CBD oil

By CL Editor31st October 2017

Another exciting report. Breast cancer tumour shrinks from 33mm to 11mm in around a month of...